# Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior

Study · id `cardio:ct-nct05767385` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05767385](<https://clinicaltrials.gov/study/NCT05767385>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05767385

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

## Technical summary

Registry record NCT05767385. Allocation not applicable; no masking; primary purpose treatment. Start 2021-12-17 (actual); primary completion 2025-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 104 participants (enrolled count; ClinicalTrials.gov record NCT05767385, source copy `cardio:ctgov-nct05767385-2026-07-14`, retrieved 2026-10-26)
- Started: 2021-12-17 (actual) (ClinicalTrials.gov record NCT05767385, source copy `cardio:ctgov-nct05767385-2026-07-14`, retrieved 2026-10-26)
- Primary completion: 2025-12-31 (actual) (ClinicalTrials.gov record NCT05767385, source copy `cardio:ctgov-nct05767385-2026-07-14`, retrieved 2026-10-26)
- Completion: 2025-12-31 (actual) (ClinicalTrials.gov record NCT05767385, source copy `cardio:ctgov-nct05767385-2026-07-14`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05767385, source copy `cardio:ctgov-nct05767385-2026-07-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05767385-2026-07-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
- Condition: Congenital Heart Disease in Children
- Condition: Hypoxia
- Condition: Neurodevelopmental Disorders
- Condition: Complex Congenital Heart Disease
- Intervention (Procedure): Single Arm
- Intervention (Procedure): Neonatal Neurobehavioral Scale
- Lead sponsor: University of Utah
- Lead sponsor class: OTHER
- Collaborator: Primary Children's Hospital
- Collaborator class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as the lead sponsor: University of Utah (`cardio:org-university-of-utah`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

## Provenance

Content hash: 11718ac8e41eb9a370ef330ed1f0cb6c5ac19b78c83b8a853af730b16fba2412
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
